Clinical Trial Update: To Evaluate Effects of AZD1446, Placebo and Donepezil in Patients With Alzheimer's Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating AZD1446 with placebo and donepezil in Alzheimer's disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• AZD1446
• Donepezil (donepezil)

Snippet

Sponsor: AstraZeneca | Conditions: Alzheimer´s Disease | Phase 2 | Status: TERMINATED